Press release
Electroceuticals: Powering the Future of Medicine | Bioelectricals Medicine Market Exhibiting a CAGR of 7.4% By 2032
Electroceuticals/Bioelectricals Medicine Market
Electroceuticals/Bioelectric Medicine Market in Short:
CAGR: 7.4%
Current Market Size: USD 40.5 Billion
Fastest Growing Region: APAC
Largest Market: North America
Projection Time: 2023-2032
Base Year: 2023
Request Downloadable Sample Copy of Report:
https://www.alliedmarketresearch.com/request-sample/A07649
How it Works?
Electroceuticals involve the use of implantable or non-invasive devices to modulate the body's electrical signals. These devices, such as pacemakers, deep brain stimulators, and vagus nerve stimulators, interact with the nervous system to treat conditions ranging from cardiac arrhythmias to chronic pain.
What are electroceuticals?
Electroceuticals are medical devices that use electrical impulses to modulate neural circuits, tissues, or organs for therapeutic purposes. They offer a non-pharmacological approach to treating various conditions such as chronic pain, neurological disorders, and psychiatric conditions.
What are the key drivers in the electroceuticals market report?
The major factor that fuels the growth of the electroceuticals market are increasing prevalence of chronic diseases, advancements in technology, and rising demand for non-invasive therapies.
Value Propositions Related to The Report:
• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on 'Strategic Developments' registered by leading players of the market
Enquire Your Every Doubt Here:
https://www.alliedmarketresearch.com/purchase-enquiry/A07649
Based on product, the cardiac pacemakers & implantable cardioverter defibrillators segment accounted for the largest share in 2022, accounting for almost two-thirds of the global electroceuticals/bioelectric medicine market revenue. This is primarily attributed to the increasing incidence of cardiovascular diseases like arrhythmias and heart failure, continuous innovations in cardiac device technology, expanding aging demographic, and heightened awareness regarding cardiovascular health and advanced treatment alternatives. These factors collectively contribute to the segment's continued dominance in revenue generation.
Based on application, the arrhythmia segment accounted for the largest share in 2022, accounting for almost two-thirds of the global electroceuticals/bioelectric medicine market revenue. This is primarily attributed to increasing prevalence of arrhythmias globally. Factors such as aging population, lifestyle changes, and advancements in arrhythmia management technologies contribute to sustained demand for diagnostic and treatment solutions in this segment.
Top Leading Key Companies -
• Medtronic
• Abbott Laboratorie
• Boston Scientific Corporation
• Cochlear Ltd.
• LivaNova PLC
• Biotronik SE & Co. KG
• ElectroCore, Inc.
• Sonova
• Nevro Corp.
• Stimwave LLC.
Market: By Region Outlook
• North America (U.S., Canada, Mexico)
• Europe (UK, Germany, France, Spain, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific)
• LAMEA (Brazil, South Africa, Turkey, Saudi Arabia, Rest of LAMEA)
Procure Complete Report @
https://www.alliedmarketresearch.com/electroceuticals-bioelectric-medicine-market/purchase-options
Important Questions Being Answered by This Market Report Are -
Q1. What is the total market value of electroceuticals market report?
Q2. What would be forecast period in the market report?
Q3. What is the market value of electroceuticals market in 2032?
Q4. Which is base year calculated in the electroceuticals market report?
Key findings of the study -
• In February 2023, LivaNova launched a new device called SenTiva DUO, an implantable pulse generator that aims to treat epilepsy in patients resistant to drug therapy. The device is specifically intended to deliver Vagus Nerve Stimulation (VNS) therapy and has a dual-pin header. The latest technology treats and offers benefits to patients who have been embedded with a dual-pin lead and IPG.
• In May 2022, Microport received approval for its platinum implantable cardioverter defibrillator (ICD) from Chinas National Medical Products Administration (NMPA). The platinum ICD was the first ICD product introduced by MicroPort Soaring CRM (Shanghai) Co., Ltd. (MSC).
𝗖𝗼𝗻𝘁𝗮𝗰𝘁:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Electroceuticals: Powering the Future of Medicine | Bioelectricals Medicine Market Exhibiting a CAGR of 7.4% By 2032 here
News-ID: 3622159 • Views: …
More Releases from Allied Market Research
PVC Additives Market 2026: A Comprehensive Analysis and Region-Wise Future Oppor …
Allied Market Research published a report, titled, "PVC Additives Market by Type (Stabilizers, Impact Modifiers, Processing Aids, Lubricants, Plasticizers, and Others) and Application (Pipes and Fittings, Profiles and Tubing, Wire and Cable, Rigid Sheet and Panel, and Others): Global Opportunity Analysis and Industry Forecast, 2024-2033". According to the report, the "PVC additives market" was valued at $6.1 billion in 2023, and is estimated to reach $10.7 billion by 2033, growing…
![[CAGR of 5%] Specialty Gas Market Analysis: Trends and Projections, 2031](https://cdn.open-pr.com/L/2/L225576879_g.jpg)
[CAGR of 5%] Specialty Gas Market Analysis: Trends and Projections, 2031
Specialty Gas Market size is set to showcase notable expansion from 2021 to 2031. Based on region, North America held the highest market share in terms of revenue in 2021, accounting for more than one-third of the global specialty gas market, and is likely to dominate the market during the forecast period. The rise in the automotive and healthcare sectors is influencing the growth of the specialty gas market. Also,…
![[CAGR of 5.5%] Synthetic Pesticide Market May Set New Growth and Forecast by 2031](https://cdn.open-pr.com/L/2/L225358552_g.jpg)
[CAGR of 5.5%] Synthetic Pesticide Market May Set New Growth and Forecast by 203 …
Allied Market Research published a report, titled, "Synthetic Pesticide Market by Category (Organophosphates, Carbamate, Others), by Type (Insecticides, Fungicides, Herbicides, Others), by Application (Fruits and Vegetables, Turfs and Ornamentals, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031." According to the report, the global synthetic pesticide industry was estimated at $16.3 billion in 2021, and is anticipated to hit $27.6 billion by 2031, registering a CAGR of 5.5% from 2022 to…
![[CAGR of 7.6%] Tetrahydrofuran (THF) Market Size, CAGR, Competitive Analysis and Forecast To 2031](https://cdn.open-pr.com/L/2/L225572903_g.jpg)
[CAGR of 7.6%] Tetrahydrofuran (THF) Market Size, CAGR, Competitive Analysis and …
As per the report published by Allied Market Research, the global tetrahydrofuran (THF) market was pegged at $3.9 billion in 2021, and is estimated to reach $8.2 billion by 2031, growing at a CAGR of 7.6% from 2022 to 2031. The report provides an in-depth analysis of top segments, changing market trends, value chain, key investment pockets, competitive scenario, and regional landscape. The report is an essential and helpful source…
More Releases for Electroceuticals
Key Trends Influencing the Growth of the Electroceuticals Market in 2025: Transf …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Electroceuticals Market Through 2025?
In recent years, the electroceuticals market has witnessed robust growth. The market size, which stands at $22.76 billion in 2024, is set to expand to $24.19 billion in 2025, signaling a compound annual growth rate (CAGR) of 6.3%.…
Electroceuticals Market Stimulating Innovation, Improving Lives: The Rise of the …
Electroceuticals Market to reach over USD 29.06 billion by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Electroceuticals Market Size, Share & Trends Analysis Report By Product (Pacemaker, ICD, Cochlear Implant, Deep Brain, Spinal Cord, Vagus, Sacral Nerve Stimulators), Application (Ischemia, Epilepsy), Type (Implantable, Noninvasive), End User (Hospitals, Clinics, & ASCs)- Market Outlook And Industry…
UK Electroceuticals Market Size & Growth Analysis Report, 2019-2025
The UK electroceuticals market is expected to grow at a CAGR of 7.5% during the forecast period. UK has the highest number of cardiovascular diseases, coronary heart disease, stroke, heart failure, atrial fibrillation, and other heart patients in Europe. Prolonged diseases, such as arthritis, asthma, chronic obstructive pulmonary disease, diabetes, and other heart-related diseases put economic burden on the UK government, which includes cost of premature fatalities, hospital stay, and…
Electroceuticals Market Size, Share and Forecast 2019-2025
The global electroceuticals market is expected to grow at a CAGR of 7.1% during the forecast period. The global electroceuticals market is expected to grow significantly owing to various factors such as rising incidence and prevalence rate of chronic diseases, and growing investment for the development of advanced electroceuticals by major players as well as the government. Increasing prevalence of neurological disorders such as epilepsy, Parkinson’s, Paraneoplastic Neurologic Syndrome, migraine,…
UK Electroceuticals Market Size, Share & Forecast 2019-2025
UK has one of the finest healthcare systems in the EU region, which enables it to provide quality healthcare to the individuals. UK has the highest number of cardiovascular diseases, coronary heart disease, stroke, heart failure, atrial fibrillation, and other heart patients. According to British Heart Foundation, more than one-fourth of the fatalities in UK occur due to `, and it is responsible for around 1.6 million fatalities each year.
Request…
North American Electroceuticals Market Growth, Size & Forecast to 2025
The market growth in North America can be attributed to the rising geriatric population, frequent US FDA approvals for innovative electroceutical devices, and growing adoption of minimally invasive/non-invasive surgeries for treatment of several diseases owing to growing awareness among patients related to electroceuticals. The geriatric population is more inclined to the risk of heart strokes. According to WHO, the incidence and prevalence rate of heart attacks are highest in North…
